Cargando…

The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models

BACKGROUND: Interventions to protect young infants against respiratory syncytial virus (RSV) are in advanced phases of development and are expected to be available in the foreseeable future. Gavi, the Vaccine Alliance, included maternal vaccines and infant monoclonal antibodies for RSV as part of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baral, Ranju, Li, Xiao, Willem, Lander, Antillon, Marina, Vilajeliu, Alba, Jit, Mark, Beutels, Philippe, Pecenka, Clint
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342012/ https://www.ncbi.nlm.nih.gov/pubmed/32586761 http://dx.doi.org/10.1016/j.vaccine.2020.06.036

Ejemplares similares

Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries
por: Li, Xiao, et al.
Publicado: (2020)

Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective
por: Wittenauer, Rachel, et al.
Publicado: (2023)

Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2019)

Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model
por: Baral, Ranju, et al.
Publicado: (2021)

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2021)

The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach
por: Antillón, Marina, et al.
Publicado: (2023)

Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage
por: Baral, Ranju, et al.
Publicado: (2020)

Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries
por: Mahmud, Sarwat, et al.
Publicado: (2023)

Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates
por: Baral, Ranju, et al.
Publicado: (2020)

Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study
por: Birger, Ruthie, et al.
Publicado: (2022)

Estimating the Economic Impact of Respiratory Syncytial Virus and Other Acute Respiratory Infections Among Infants Receiving Care at a Referral Hospital in Malawi
por: Baral, Ranju, et al.
Publicado: (2020)

Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
por: Löwensteyn, Yvette N., et al.
Publicado: (2021)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Correction to: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
por: Löwensteyn, Yvette N., et al.
Publicado: (2021)

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
por: Bilcke, Joke, et al.
Publicado: (2019)

Challenges to sustainable immunization systems in Gavi transitioning countries
por: Cernuschi, Tania, et al.
Publicado: (2018)

Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis
por: Laufer, Rachel S., et al.
Publicado: (2023)

Health and economic impact of rotavirus vaccination in GAVI-eligible countries
por: Kim, Sun-Young, et al.
Publicado: (2010)

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa
por: Koltai, Mihaly, et al.
Publicado: (2023)

Lessons learned from the Advancing Maternal Immunization collaboration: identifying evidence gaps for informed respiratory syncytial virus maternal immunization decision-making
por: Groman, Devin, et al.
Publicado: (2019)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

Gavi HPV Programs: Application to Implementation
por: Hanson, Celina M., et al.
Publicado: (2015)

Respiratory Syncytial Virus (RSV) Disease and Prevention Products: Knowledge, Attitudes, and Preferences of Kenyan Healthcare Workers in Two Counties in 2021
por: Nyawanda, Bryan O., et al.
Publicado: (2023)

Exploring the influence of the Global Fund and the GAVI Alliance on health systems in conflict-affected countries
por: Patel, Preeti, et al.
Publicado: (2015)

Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries
por: Saxenian, Helen, et al.
Publicado: (2015)

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country
por: Burger, Emily A., et al.
Publicado: (2018)

Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction
por: Soble, Adam, et al.
Publicado: (2020)

Assessment of gestational age at antenatal care visits among Kenyan women to inform delivery of a maternal respiratory syncytial virus (RSV) vaccine in low- and middle-income countries
por: Nyiro, Joyce U., et al.
Publicado: (2023)

Evaluating Country Performance After Transitioning From Gavi Assistance: An Applied Synthetic Control Analysis
por: Kolesar, Robert John, et al.
Publicado: (2023)

The GAVI Alliance and the ‘Gates approach’ to health system strengthening
por: Storeng, Katerini T.
Publicado: (2014)

Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal()
por: Chu, Helen Y., et al.
Publicado: (2017)

Adjustable Algorithmic Tool for Assessing the Effectiveness of Maternal Respiratory Syncytial Virus (RSV) Vaccination on Infant Mortality in Developing Countries
por: Cevigney, Rachel, et al.
Publicado: (2021)

Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling study
por: Do, Lien Anh Ha, et al.
Publicado: (2023)

Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries
por: Debellut, Frédéric, et al.
Publicado: (2018)

Nasal and Fecal Microbiota and Immunoprofiling of Infants With and Without RSV Bronchiolitis
por: Alba, Claudio, et al.
Publicado: (2021)

The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya
por: Ochola, Rachel, et al.
Publicado: (2009)

Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022
por: Fitzpatrick, Meagan C., et al.
Publicado: (2023)

The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study
Publicado: (2019)

How to evaluate the implementation of complex health programmes in low-income settings: the approach of the Gavi Full Country Evaluations
por: Soi, Caroline, et al.
Publicado: (2020)

Has Gavi lived up to its promise? Quasi-experimental evidence on country immunisation rates and child mortality
por: Jaupart, Pascal, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iv1v3m46gn7kv36fr6mq21posd